In type 2 diabetes mellitus patients, (Glimepiride 1mg + Metformin 500mg) complements diet and exercise:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Losucon M 2/500 SR Tablet is a combination medication containing Glimepiride and Metformin, both belonging to the group of Antidiabetic agents. It's used for treating type 2 diabetes mellitus when diet, exercise, and a single agent aren't enough for proper glycemic control. Type 2 diabetes is a chronic condition where the body lacks sufficient insulin or the produced insulin doesn't function effectively. Symptoms include excessive urination, thirst, hunger, fatigue, and blurred vision.
Glimepiride stimulates insulin production from the pancreas and enhances insulin utilization, thereby lowering blood sugar. Metformin, a biguanide, reduces liver sugar release into the bloodstream. Complementing Losucon M 2/500 SR Table with regular exercise and a prescribed diet plan is advised for optimal results.
Before starting Losucon M 2/500 SR Table, inform your doctor about type 1 diabetes, diabetic ketoacidosis, severe liver or kidney issues, and acute heart problems. Notify if you're pregnant or breastfeeding. It's not suitable for children or adolescents under 18 years. Alcohol consumption should be avoided during Losucon M 2/500 SR Table treatment, as it can alter its blood sugar-lowering effects and increase lactic acidosis risk. Common side effects include taste changes, nausea, diarrhea, stomach pain, and vomiting. If symptoms worsen, consult your doctor.
It is recommended to avoid taking Losucon M 2/500 SR Tablet during pregnancy, as it may pose a risk of harm to the unborn baby. If you are planning to become pregnant, inform your doctor so that alternative treatment options can be considered.
Take Losucon M 2/500 SR Tablet with caution if you have a history of liver or kidney diseases/conditions. Your doctor may need to adjust the dose based on your medical history.
Take Losucon M 2/500 SR Tablet with caution if you have a history of liver or kidney diseases/conditions. Your doctor may need to adjust the dose based on your medical history.
Type 2 Diabetes Mellitus
Losucon M 2/500 SR Tablet regulates blood glucose levels by combining the actions of its two components. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases liver glucose production, delays absorption from the intestines, and enhances insulin sensitivity.
Common:
Rare:
Stop taking Losucon M 2/500 SR Tablet and contact your doctor immediately if you experience the following side effects:
Losucon M 2/500 SR Tablet is used to treat type 2 diabetes mellitus; when diet, exercise, and glimepiride or metformin alone are not able to control the blood sugar levels.
Glimepiride's mode of action primarily involves increasing insulin release from pancreatic beta cells and enhancing insulin sensitivity in peripheral tissues, while Metformin Hydrochloride mainly works by reducing hepatic glucose production, lowering intestinal glucose absorption, and improving insulin sensitivity without causing hypoglycemia. This combination of actions helps to effectively lower blood glucose levels in individuals with type 2 diabetes. Well done!
For the treatment of type 2 diabetes mellitus, here are the dosage guidelines for Losucon M 2/500 SR Tablet:
Adult Dose:
Maximum Recommended Dose:
Dosage Individualization:
Administration:
Medical Guidance:
Please note that following your healthcare provider's instructions and regular monitoring are crucial for managing your diabetes effectively. Always consult your doctor before making any changes to your medication regimen.
In the case of Glimepiride:
Regarding Metformin:
Note that careful consideration and medical supervision are crucial when combining medications to manage potential interactions and their effects. Always consult your healthcare provider before making any changes to your medication regimen.
For Glimepiride:
For Metformin:
Pregnancy:
For Glimepiride:
For Metformin:
Lactation:
Glimepiride should not be used by breastfeeding mothers to avoid the potential transmission to the infant via breast milk.
If needed, patients should consider switching to insulin or discontinuing nursing.
Metformin's presence in human breast milk is uncertain, and a decision should be made considering the benefits of the medication for the mother against potential risks to the nursing infant.
For Glimepiride:
For Metformin:
Store in a cool (nothing above 25°C) and dry location away from light.